Costa Jéssica P, Islam Md T, Santos Pauline S, Ferreira Paula B, Oliveira George L S, Alencar Marcus V O B, Paz Marcia F C J, Ferreira Éverton L F, Feitosa Chistiane M, Citó Antonia M G L, Sousa Damião P, Melo-Cavalcante Ana Amelia C
Laboratory of Research in Experimental Neurochemistry, Postgraduate Program in Biotechnology, Northeast Biotechnology Network (RENORBIO), Federal University of Piauí, Teresina (PI)-64.049-550, Brazil.
Curr Pharm Biotechnol. 2016;17(14):1278-1284. doi: 10.2174/1389201017666161019155715.
Phytol (3,7,11,15-tetramethylhexadec-2-en-1-ol; PHY), the alcoholic diterpenoid is particularly interesting due to its diverse activities found in literature. This study evaluated in vitro and in vivo antioxidant capacity of PHY.
We conducted DPPH• (2,2-diphenyl-1-picrylhydrazyl) and ABTS•+ (2,2'-azino-bis(3- ethylbenzthiazoline-6-sulphonic acid)) radical scavenging tests as in vitro, while Saccharomyces cerevisiae test as in vivo. For in vitro tests, trolox and for in vivo test hydrogen peroxide (H2O2) were taken as standard and stressor, respectively. Additionally, we measured the superoxide dismutase (SOD), catalase (CAT), reduced glutathione (GSH), lipid peroxidation (LP) and nitrite (NO2 -) contents in mouse hippocampus taking 0.05% Tween 80 dissolved in 0.9% saline (0.25 ml) and ascorbic acid (250 mg/kg; AA) as vehicle and standard, respectively. PHY was administered at doses 25, 50 and 75 mg/kg. In the latter case, all the treatments were administered via intraperitoneal (i.p.) route.
PHY at 7.2 μg/ml exhibited 59.89 ± 0.73% and 62.79 ± 1.99% scavenging capacity of DPPH• and ABTS•+, respectively. In S. cerevisiae strains, PHY showed prominent protective effects. Moreover, in Swiss mouse hippocampus; PHY reduced the LP and NO2 - contents, while increased in GSH, SOD and CAT activities.
PHY exerted antioxidant potential in our current non- and preclinical test systems and can be a good candidate for the development of treatments of oxidative stress mediated diseases.
叶绿醇(3,7,11,15 - 四甲基十六 - 2 - 烯 - 1 - 醇;PHY),这种醇类二萜因其文献中报道的多种活性而特别引人关注。本研究评估了PHY的体外和体内抗氧化能力。
我们进行了2,2 - 二苯基 - 1 - 苦基肼(DPPH•)和2,2'- 联氮 - 双 -(3 - 乙基苯并噻唑啉 - 6 - 磺酸)(ABTS•+)自由基清除试验作为体外实验,而酿酒酵母试验作为体内实验。对于体外试验,以Trolox为标准,对于体内试验,以过氧化氢(H2O2)作为应激源。此外,我们以溶解于0.9%生理盐水(0.25 ml)中的0.05%吐温80和抗坏血酸(250 mg/kg;AA)分别作为溶剂和标准,测量了小鼠海马体中的超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、还原型谷胱甘肽(GSH)、脂质过氧化(LP)和亚硝酸盐(NO2 -)含量。PHY以25、50和75 mg/kg的剂量给药。在后一种情况下,所有处理均通过腹腔注射(i.p.)途径给药。
7.2 μg/ml的PHY对DPPH•和ABTS•+的清除能力分别为59.89 ± 0.73%和62.79 ± 1.99%。在酿酒酵母菌株中,PHY显示出显著的保护作用。此外,在瑞士小鼠海马体中;PHY降低了LP和NO2 - 含量,同时增加了GSH、SOD和CAT的活性。
在我们当前的非临床和临床前测试系统中,PHY发挥了抗氧化潜力,并且可能是开发氧化应激介导疾病治疗方法的良好候选物。